Junji Bio

Suzhou, China · Founded 2020 · Privately Held (backing)

Developer of biosynthesis designed to provide overall solutions for molecular diagnosis, nucleic acid chemistry, synthetic biology and antibody drug development. Junji Bio is based in Suzhou, China and was founded in 2020. It has raised $14.1 million.

Last price · $/share
—
Implied valuation
—
Total raised
$14.1M
Last round
—
Valuation — not yet established

No valuation for Junji Bio is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($14.1M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Junji Bio with a free account
  • ·Watch Junji Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Junji Bio funding history

No rounds on record

No funding rounds for Junji Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How Junji Bio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Junji Bio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Junji Bio

How much has Junji Bio raised?
Junji Bio has raised $14.1M in total funding across its recorded rounds.